What is the impact of PPAR-gamma agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

Gundogdu, Burcu; Tapisiz, Omer; Dilbaz, Berna; Mulazimoglu, Serkan; Muftuoglu, Kamil; Dundar, Betul; Goktolga, Umit

doi:10.3906/sag-2002-117

What is the impact of PPAR-gamma agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

Gundogdu B., Tapisiz O. L., Dilbaz B., Mulazimoglu S. B., Muftuoglu K. H., Dundar B., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.50, sa.5, ss.1399-1408, 2020 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 50 Sayı: 5
Basım Tarihi: 2020
Doi Numarası: 10.3906/sag-2002-117
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.1399-1408
Anahtar Kelimeler: Hysterectomy, ovarian reserve, rat, Doppler ultrasonography, PPAR gamma, rosiglitazone, ANTI-MULLERIAN HORMONE, TOTAL ABDOMINAL HYSTERECTOMY, ESTROUS-CYCLE, PREMENOPAUSAL WOMEN, SERUM FSH, EXPRESSION, AGE
Ankara Üniversitesi Adresli: Evet

Özet

Background/aim: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist-rosiglitazone against ovarian reserve decrement.